Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical and Imaging Predictors of Peri-Device Leak Following Left Atrial Appendage Closure Using the LAmbre Device: A Comparative Study of CCTA and TEE.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Multi-omics and spatial transcriptomics decode the ZDHHC9-driven hypoxia-immunosuppressive axis in hepatocellular carcinoma.

Frontiers in oncology·2026
Same author

AirDC: Adaptive Iterative Depth Refinement Framework for Full-Range Metric Depth Completion.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Accuracy of Two Novel Self-Contained Darkroom Refractive Screeners Compared with Cycloplegic Retinoscopy and a Traditional Autorefractor in Schoolchildren.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Correction to: Integrating transcriptomics, network pharmacology, and GraphBAN neural networks to identify biomarkers and regulatory mechanisms of classical traditional Chinese medicine formulations in ulcerative colitis.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Identification of efficient multi-epitope combinations against African swine fever virus based on AP205 scaffold-mediated nanodisplay technology.

Journal of nanobiotechnology·2026

Related Experiment Video

Updated: May 16, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

Pediatric AML prognostication with an m6A-focused LASSO model.

Jing Zhang1, Taoli Suo1, Yanli Cheng1

  • 1Department of Hematology, Shanxi Children's Hospital, Women Health Center of Shanxi, Taiyuan, Shanxi, P.R. China.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|April 4, 2025
PubMed
Summary

This study reveals unique N6-methyladenosine (m6A)-related gene expression patterns in pediatric acute myeloid leukemia (pAML). These findings highlight m6A genes as potential prognostic markers for personalized AML treatment strategies.

Keywords:
LASSO risk regression modelacute myeloid leukemiachildrenhigh-throughput transcriptome sequencingm6A RNA methylationprognosissingle-cell RNA sequencing

More Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.1K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.1K

Related Experiment Videos

Last Updated: May 16, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.1K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Acute myeloid leukemia (AML) exhibits diverse prognoses in pediatric and adult patients.
  • Dysregulation of N6-methyladenosine (m6A)-related genes is implicated in AML pathogenesis.

Purpose of the Study:

  • To identify distinct m6A gene expression patterns in pediatric AML (pAML).
  • To develop a prognostic model using m6A-related genes for AML patients.
  • To assess the clinical utility of m6A genes in predicting AML outcomes.

Main Methods:

  • Analysis of single-cell RNA sequencing data from the Gene Expression Omnibus (GEO).
  • Development of a LASSO (Least Absolute Shrinkage and Selection Operator) risk regression model.
  • Evaluation of m6A gene expression profiles in pediatric and adult AML cohorts.

Main Results:

  • Distinct m6A gene expression patterns were identified specifically in pediatric AML cases.
  • The LASSO risk regression model demonstrated the prognostic value of m6A-related genes.
  • m6A-related genes showed significant potential in predicting AML patient outcomes across different subsets.

Conclusions:

  • Pediatric AML displays unique m6A gene expression profiles with prognostic significance.
  • m6A-related genes are valuable predictors for AML prognosis.
  • These findings support the use of m6A genes as biomarkers for personalized AML treatment strategies.